Stocktoria
MEDICINOVA INC MNOV
Nasdaq · stock · Pharmaceutical Preparations · website · IPO 2006-12-01
MEDICINOVA INC financials (annual)
Bars are annual figures from 2016 to 2025; red bars are negative (a loss or cash outflow).
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $409,657 | — | $1.0M | — | $4.0M | — | — | — | — | — |
| R&D expense | $6.7M | $6.8M | $5.3M | $8.7M | $8.1M | $7.1M | $5.7M | $5.3M | $3.9M | $3.1M |
| Operating income | -$13.3M | -$12.7M | -$9.9M | -$14.6M | -$10.2M | -$14.2M | -$14.0M | -$15.6M | -$13.0M | -$10.9M |
| Interest expense | — | — | — | — | — | — | — | — | $298 | $454 |
| Income tax | $5,994 | $5,537 | $3,047 | $2,822 | $2,568 | -$1,648 | $12,660 | $5,276 | -$1.7M | $3,754 |
| Net income | -$12.0M | -$11.0M | -$8.6M | -$14.1M | -$10.1M | -$13.9M | -$12.9M | -$14.7M | -$11.2M | -$10.9M |
| EPS (diluted) | $-0.24 | $-0.23 | $-0.17 | $-0.29 | $-0.21 | — | — | — | — | — |
| Operating cash flow | -$9.8M | -$10.6M | -$7.4M | -$12.9M | -$9.4M | -$10.8M | -$9.1M | -$9.1M | -$6.9M | -$6.5M |
| Free cash flow | -$9.8M | -$10.6M | -$7.5M | -$12.9M | -$9.4M | -$10.9M | -$9.1M | -$9.1M | — | -$6.6M |
| Cash & equivalents | $30.8M | $40.4M | $51.0M | $18.5M | $71.4M | $60.0M | $63.8M | $62.3M | $28.0M | $24.1M |
| Total assets | $45.6M | $55.9M | $66.3M | $74.2M | $87.4M | $75.4M | $79.2M | $77.2M | $43.4M | $39.8M |
| Total liabilities | $4.0M | $3.4M | $3.9M | $3.9M | $3.7M | $4.1M | $4.3M | $4.1M | $4.8M | $5.3M |
| Shareholders' equity | $41.6M | $52.5M | $62.4M | $70.2M | $83.7M | $71.3M | $74.9M | $73.1M | $38.6M | $34.5M |
Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.